Security key
800677106
SANGAMO THERAPEUTICS, INC - Common Stock, $0.01 par value per share (SGMOQ)
CUSIP: 800677106
Q3 2023 13F Holders as of 30 Sep 2023
- Security type / class
- Equity / Common Stock, $0.01 par value per share
- Total 13F shares
- 102,314,735
- Total 13F value
- $61,341,591
- Share change
- -3,530,192
- Put/Call ratio
- 123%
- SEC-reported price per share
- $0.60
- Number of holders
- 131
- Value change
- -$4,250,211
- Number of buys
- 42
- Number of sells
- 73
- Shares outstanding
- 414,359,662
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2023
Institutions
131
Top holders
10
SGMOQ full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
SANGAMO THERAPEUTICS, INC SEC filings
SANGAMO THERAPEUTICS, INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 800677106
Recent filing periods:
Ownership snapshot
Top reported holders of SGMOQ - SANGAMO THERAPEUTICS, INC - Common Stock, $0.01 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
WASATCH ADVISORS LP
Disclosed value leader
WASATCH ADVISORS LP
Comparable rows
15/15
Latest evidence
30 Jun 2023
13F
Lead comparable stake: 4.1%
Showing 1-6 of 15 holder rows.
Quick read
WASATCH ADVISORS LP leads the comparable SEC ownership view at 4.1%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens WASATCH ADVISORS LP's linked filing trail.
Comparable ownership
Top 5
WASATCH ADVISORS LP
4.1%
BlackRock Finance, Inc.
3.8%
VANGUARD GROUP INC
3%
Rokos Capital Management LLP
1.6%
CITADEL ADVISORS LLC
1.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| WASATCH ADVISORS LP |
13F
Company
|
4.1%
|
$22,168,172
17,052,440 shares
|
— | 30 Jun 2023 |
| BlackRock Finance, Inc. |
13F
Company
|
3.8%
|
$20,655,669
15,888,976 shares
|
— | 30 Jun 2023 |
| VANGUARD GROUP INC |
13F
Company
|
3%
|
$16,117,936
12,398,412 shares
|
— | 30 Jun 2023 |
| Rokos Capital Management LLP |
13F
Company
|
1.6%
|
$8,060,563
6,474,348 shares
|
— | 30 Jun 2023 |
| CITADEL ADVISORS LLC |
13F
Company
|
1.1%
|
$5,843,517
4,495,013 shares
|
— | 30 Jun 2023 |
| CREDIT SUISSE AG/ |
13F
Company
|
0.89%
|
$4,810,000
3,700,000 shares
|
— | 30 Jun 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
131
Shares
102,314,735
Rows available
131
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2023 vs Q2 2023 Across Filers
Q2 2023 holders
149
Q3 2023 holders
131
Holder diff
-18
| Investor | Q2 2023 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q2 2023 value | Q3 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend